// COMPANY
SPR Therapeutics
SECTOR HEALTHTECHMENTIONS 2LAST SEEN JUNE 8, 2026
// OVERVIEW
Cleveland-based provider of peripheral nerve stimulation therapies for chronic pain management; raised ~$172M from VCs before $650M acquisition by Medtronic.
// RECENT MENTIONS
// SIGNALS
2 SIGNALS
01
m_and_a·Axios Pro Rata·JUNE 8, 2026
“Incyte agreed to acquire Vega Therapeutics… for up to $2b ($1.25b upfront) from VC-backed Star Therapeutics.”
02
m_and_a·Axios Pro Rata·MAY 21, 2026
“Medtronic agreed to acquire SPR Therapeutics, a Cleveland-based provider of peripheral nerve stimulation therapies for chronic pain management, for $650m in cash.”
AI-extracted from podcast / newsletter / paper summaries. May contain errors.